Skip Header

Contribute Send feedback
Read comments (?) or add your own

Q16719 (KYNU_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 105. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Kynureninase

EC=3.7.1.3
Alternative name(s):
L-kynurenine hydrolase
Gene names
Name:KYNU
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length465 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3-hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity.

Catalytic activity

L-kynurenine + H2O = anthranilate + L-alanine. Ref.1 Ref.2 Ref.6 Ref.7

L-3-hydroxykynurenine + H2O = 3-hydroxyanthranilate + L-alanine. Ref.1 Ref.2 Ref.6 Ref.7

Cofactor

Pyridoxal phosphate.

Enzyme regulation

Inhibited by o-methoxybenzoylalanine (OMBA). Ref.1 Ref.2

Pathway

Amino-acid degradation; L-kynurenine degradation; L-alanine and anthranilate from L-kynurenine: step 1/1.

Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from L-kynurenine: step 2/3.

Subunit structure

Homodimer. Ref.7

Subcellular location

Cytoplasm Ref.1.

Tissue specificity

Expressed in all tissues tested (heart, brain placenta, lung, liver, skeletal muscle, kidney and pancreas). Highest levels found in placenta, liver and lung. Expressed in all brain regions. Ref.1 Ref.2

Induction

Increased levels in several cerebral and systemic inflammatory conditions. Ref.1 Ref.2

Involvement in disease

Note=Xanthurenic aciduria manifesting as massive urinary excretion of large amounts of kynurenine, 3-hydroxykynurenine and xanthurenic acid has been observed in an individual carrying a homozygous missense change in KYNU (Ref.8). The urinary pattern in the patient suggests kynureninase deficiency and a block in the conversion of kynurenine and 3-hydroxykynurenine to anthranilate and 3-hydroxyanthranilate, respectively.

Sequence similarities

Belongs to the kynureninase family.

Caution

It has been reported that this enzyme possesses no measurable activity against L-kynurenine and is subject to inhibition by both L-kynurenine and D-kynurenine at pH 7.9 (Ref.6).

Biophysicochemical properties

Kinetic parameters:

KM=493 µM for L-kynurenine (at pH 7.0) Ref.1 Ref.2 Ref.6 Ref.7

KM=28.3 µM for DL-3-hydroxykynurenine (at pH 7.0)

KM=3.0 µM for DL-3-hydroxykynurenine (at pH 7.9)

pH dependence:

Optimum pH is 8.25 with DL-3-hydroxykynurenine as substrate.

Mass spectrometry

Molecular mass is 52400 Da from positions 1 - 465. Determined by MALDI. The reported mass is given to only three significant figures. Ref.6

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 465465Kynureninase
PRO_0000218657

Regions

Region165 – 1684Pyridoxal phosphate binding

Sites

Binding site1371Pyridoxal phosphate; via amide nitrogen By similarity
Binding site1381Pyridoxal phosphate
Binding site2501Pyridoxal phosphate
Binding site2531Pyridoxal phosphate
Binding site2751Pyridoxal phosphate
Binding site3051Pyridoxal phosphate
Binding site3331Pyridoxal phosphate

Amino acid modifications

Modified residue11N-acetylmethionine By similarity
Modified residue2761N6-(pyridoxal phosphate)lysine

Natural variations

Natural variant1881R → Q.
Corresponds to variant rs2304705 [ dbSNP | Ensembl ].
VAR_049724
Natural variant1981T → A Detected in a boy with xanthurenic aciduria. Ref.8
VAR_054401
Natural variant4121K → E. Ref.3
Corresponds to variant rs9013 [ dbSNP | Ensembl ].
VAR_022092

Secondary structure

....................................................................................... 465
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Q16719 [UniParc].

Last modified November 1, 1996. Version 1.
Checksum: BDD136BE18C79EBB

FASTA46552,352
        10         20         30         40         50         60 
MEPSSLELPA DTVQRIAAEL KCHPTDERVA LHLDEEDKLR HFRECFYIPK IQDLPPVDLS 

        70         80         90        100        110        120 
LVNKDENAIY FLGNSLGLQP KMVKTYLEEE LDKWAKIAAY GHEVGKRPWI TGDESIVGLM 

       130        140        150        160        170        180 
KDIVGANEKE IALMNALTVN LHLLMLSFFK PTPKRYKILL EAKAFPSDHY AIESQLQLHG 

       190        200        210        220        230        240 
LNIEESMRMI KPREGEETLR IEDILEVIEK EGDSIAVILF SGVHFYTGQH FNIPAITKAG 

       250        260        270        280        290        300 
QAKGCYVGFD LAHAVGNVEL YLHDWGVDFA CWCSYKYLNA GAGGIAGAFI HEKHAHTIKP 

       310        320        330        340        350        360 
ALVGWFGHEL STRFKMDNKL QLIPGVCGFR ISNPPILLVC SLHASLEIFK QATMKALRKK 

       370        380        390        400        410        420 
SVLLTGYLEY LIKHNYGKDK AATKKPVVNI ITPSHVEERG CQLTITFSVP NKDVFQELEK 

       430        440        450        460 
RGVVCDKRNP NGIRVAPVPL YNSFHDVYKF TNLLTSILDS AETKN 

« Hide

References

« Hide 'large scale' references
[1]"Isolation and expression of a cDNA clone encoding human kynureninase."
Alberati-Giani D., Buchli R., Malherbe P., Broger C., Lang G., Koehler C., Lahm H.-W., Cesura A.M.
Eur. J. Biochem. 239:460-468(1996) [PubMed: 8706755] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY, CATALYTIC ACTIVITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES.
Tissue: Hepatoma.
[2]"Cloning and recombinant expression of rat and human kynureninase."
Toma S., Nakamura M., Tone S., Okuno E., Kido R., Breton J., Avanzi N., Cozzi L., Speciale C., Mostardini M., Gatti S., Benatti L.
FEBS Lett. 408:5-10(1997) [PubMed: 9180257] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, CATALYTIC ACTIVITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES.
Tissue: Liver.
[3]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT GLU-412.
Tissue: Synovium.
[4]"Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[5]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]"Purification and biochemical characterization of some of the properties of recombinant human kynureninase."
Walsh H.A., Botting N.P.
Eur. J. Biochem. 269:2069-2074(2002) [PubMed: 11985583] [Abstract]
Cited for: MASS SPECTROMETRY, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES.
[7]"Crystal structure of Homo sapiens kynureninase."
Lima S., Khristoforov R., Momany C., Phillips R.S.
Biochemistry 46:2735-2744(2007) [PubMed: 17300176] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL PHOSPHATE, HOMODIMERIZATION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES.
[8]"Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase."
Christensen M., Duno M., Lund A.M., Skovby F., Christensen E.
J. Inherit. Metab. Dis. 30:248-255(2007) [PubMed: 17334708] [Abstract]
Cited for: VARIANT ALA-198, POSSIBLE INVOLVEMENT IN XANTHURENIC ACIDURIA.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
U57721 mRNA. Translation: AAC50650.1.
AK315343 mRNA. Translation: BAG37742.1.
CR457423 mRNA. Translation: CAG33704.1.
CH471058 Genomic DNA. Translation: EAX11600.1.
CH471058 Genomic DNA. Translation: EAX11601.1.
IPIIPI00003818.
PIRG02652.
RefSeqNP_001186170.1. NM_001199241.1.
NP_003928.1. NM_003937.2.
UniGeneHs.470126.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
2HZPX-ray2.00A1-465[»]
3E9KX-ray1.70A1-465[»]
ProteinModelPortalQ16719.
SMRQ16719. Positions 6-460.
ModBaseSearch...

Protein-protein interaction databases

IntActQ16719. 1 interaction.
STRINGQ16719.

PTM databases

PhosphoSiteQ16719.

Polymorphism databases

DMDM3913982.

Proteomic databases

PeptideAtlasQ16719.
PRIDEQ16719.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000264170; ENSP00000264170; ENSG00000115919.
ENST00000409512; ENSP00000386731; ENSG00000115919.
GeneID8942.
KEGGhsa:8942.
UCSCuc002tvl.1. human.

Organism-specific databases

CTD8942.
GeneCardsGC02P143657.
H-InvDBHIX0002487.
HGNCHGNC:6469. KYNU.
MIM605197. gene.
neXtProtNX_Q16719.
Orphanet79155. Encephalopathy due to hydroxykynureninuria.
PharmGKBPA30258.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG09892.
HOGENOMHBG523016.
HOVERGENHBG001170.
InParanoidQ16719.
OMATAEAHKR.
OrthoDBEOG490793.
PhylomeDBQ16719.

Enzyme and pathway databases

ReactomeREACT_111217. Metabolism.

Gene expression databases

ArrayExpressQ16719.
BgeeQ16719.
CleanExHS_KYNU.
GenevestigatorQ16719.
GermOnlineENSG00000115919. Homo sapiens.

Family and domain databases

InterProIPR000192. Aminotrans_V/Cys_dSase.
IPR010111. Kynureninase.
IPR015424. PyrdxlP-dep_Trfase_major_dom.
IPR015421. PyrdxlP-dep_Trfase_major_sub1.
IPR015422. PyrdxlP-dep_Trfase_major_sub2.
[Graphical view]
Gene3DG3DSA:3.40.640.10. PyrdxlP-dep_Trfase_major_sub1. 1 hit.
G3DSA:3.90.1150.10. PyrdxlP-dep_Trfase_major_sub2. 2 hits.
KOK01556.
PANTHERPTHR14084. Kynureninase. 1 hit.
PfamPF00266. Aminotran_5. 1 hit.
[Graphical view]
PIRSFPIRSF038800. KYNU. 1 hit.
SUPFAMSSF53383. PyrdxlP-dep_Trfase_major. 1 hit.
TIGRFAMsTIGR01814. Kynureninase. 1 hit.
ProtoNetSearch...

Other

DrugBankDB00160. L-Alanine.
DB00114. Pyridoxal Phosphate.
NextBio33630.
SOURCESearch...

Entry information

Entry nameKYNU_HUMAN
AccessionPrimary (citable) accession number: Q16719
Secondary accession number(s): B2RCZ5, D3DP79, Q6I9T2
Entry history
Integrated into UniProtKB/Swiss-Prot: December 15, 1998
Last sequence update: November 1, 1996
Last modified: January 25, 2012
This is version 105 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 2

Human chromosome 2: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PATHWAY comments

Index of metabolic and biosynthesis pathways

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families